Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPREVIO
2015-000555-24Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Crohn's disease comparing Vedolizumab with Placebo (2 arms). Primary endpoint: Severe endoscopic postoperative recurrence at approximately 6 months. Started Feb 2016; status: completed.
02
Drugs
vedolizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2015-000555-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000555-24.